Plymouth University has extensive expertise in quantitative proteomics and the analysis of MS data. The Centre for Research in Translational Medicine, together with the Systems Biology Centre at Plymouth University, brings together researchers from biomedical science, healthcare and clinical medicine to generate multidisciplinary research programs for the benefit of human health.
Within the sysVASC project, Plymouth University will perform the tissue degradomics/proteomics analysis using high resolution LC-MS/MS.Prof. Neil Avent
Neil Avent is a group leader and Head of School of Biomedical and Health Sciences at University of Plymouth. He has published extensively on the development of methods for non-invasive prenatal diagnosis by employing state of the art genomic and proteomic technologies. Neil Avent has coordinated EU Framework 5 quality of Life programme "Cell factory" (2003-2006) and has participated in other prestigious research projects at both national and international levels.
2 Heywood, W., et al. (2012). Identification of new biomarkers for Down's syndrome in maternal plasma J Proteomics. 759, 2621-2628.
3 Heywood W., et al. (2012). The development of a peptide SRM-based tandem mass spectrometry assay for prenatal screening of Down syndrome. J Proteomics. 7511,3248-3257.